Last. Amal Suhool(University Hospital Southampton NHS Foundation Trust)H-Index: 2
view all 0 authors...
BACKGROUND Based on excellent outcomes from high-volume centres, laparoscopic liver resection is increasingly being adopted into nationwide practice which typically includes low-medium volume centres. It is unknown how the use and outcome of laparoscopic liver resection compare between high-volume centres and low-medium volume centres. This study aimed to compare use and outcome of laparoscopic liver resection in three leading European high-volume centres and nationwide practice in the Netherlan...
Last. Simon Law(HKU: University of Hong Kong)H-Index: 73
view all 0 authors...
BACKGROUND Surgery is the primary treatment that can offer potential cure for gastric cancer, but is associated with significant risks. Identifying optimal surgical approaches should be based on comparing outcomes from well designed trials. Currently, trials report different outcomes, making synthesis of evidence difficult. To address this, the aim of this study was to develop a core outcome set (COS)-a standardized group of outcomes important to key international stakeholders-that should be rep...
#1Seung-Bum Ryoo(Seoul National University Hospital)H-Index: 6
#2Juhun Park(Seoul National University Hospital)H-Index: 15
Last. Kyu Joo Park(Seoul National University Hospital)H-Index: 33
view all 16 authors...
Background No effective treatment exists for anterior resection syndrome (ARS) following sphincter-saving surgery for rectal cancer. This RCT assessed the safety and efficacy of a 5-HT3 receptor antagonist, ramosetron, for ARS. Methods A single-centre, randomized, controlled, open-label, parallel group trial was conducted. Male patients with ARS 1 month after rectal cancer surgery or ileostomy reversal were enrolled and randomly assigned (1 : 1) to 5 μg of ramosetron (Irribow®) daily or conserva...